SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
RMTI

Rockwell Medical, Inc. (NASDAQ:RMTI)

US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
7.00+0.06 (+0.86%)
 
Market cap
$28.2M
Health Score
Analyst consensus
Listed since
Jan 27, 1998
Insider Score
––Not scored
RMTI Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

RMTI analyst forecast

RMTI analyst consensus

Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

RMTI 12-month price target

No published price targets in the last 12 months.

Best analysts covering RMTI

  • HC Wainwright & Co.25%success rate · 20 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

RMTI analyst ratings

FirmPrice targetAction
—HC Wainwright & Co.Buy——Reiterated2026-09-11
—HC Wainwright & Co.Buy——Reiterated2026-07-09
—HC Wainwright & Co.Buy——Reiterated2026-03-30
—HC Wainwright & Co.Buy——Reiterated2026-01-26
—HC Wainwright & Co.Buy——Reiterated2025-11-13
—HC Wainwright & Co.Buy——Reiterated2025-03-24
—HC Wainwright & Co.Buy——Reiterated2024-12-23
—HC Wainwright & Co.Buy——Reiterated2024-11-25
—HC Wainwright & Co.Buy——Reiterated2024-08-12
—HC Wainwright & Co.Buy——Reiterated2024-05-16
—HC Wainwright & Co.Buy——Reiterated2024-03-25
—HC Wainwright & Co.Buy——Reiterated2023-11-15
—HC Wainwright & Co.Buy——Reiterated2023-10-04
—HC Wainwright& Co.Buy——Reiterated2023-09-28
—HC Wainwright & Co.Buy——Reiterated2023-09-28
—HC Wainwright & Co.Buy——Reiterated2023-08-15
—HC Wainwright & Co.Buy——Reiterated2023-07-17
—HC Wainwright& Co.Buy——Reiterated2023-05-30
—HC Wainwright & Co.Buy——Reiterated2023-05-30
—HC Wainwright & Co.Buy——Reiterated2023-05-02
—HC Wainwright & Co.Buy——Reiterated2023-04-04
—HC Wainwright & Co.Buy——Reiterated2023-02-13
—HC Wainwright & Co.Buy——Reiterated2023-02-08
—HC Wainwright & Co.Buy——Reiterated2022-08-30
—HC Wainwright & Co.Buy——Reiterated2022-01-18
—HC Wainwright & Co.Buy——Reiterated2021-09-07
—HC Wainwright & Co.Buy——Reiterated2021-02-08
—HC Wainwright & Co.Buy——Reiterated2020-04-07
—Piper JaffrayOverweight——Reiterated2019-11-12
—Cantor FitzgeraldOverweight——Reiterated2019-06-25
—Piper JaffrayOverweight——Reiterated2019-06-24
—IFS SecuritiesOutperform——Downgraded2018-10-19
—IFS SecuritiesBuy——Downgraded2017-08-14
—Bank of AmericaUnderperform——Downgraded2016-11-08
—BTIG ResearchBuy——Reiterated2016-08-19
—Stifel NicolausHold——Downgraded2016-03-01
—Craig-HallumHold——Downgraded2016-03-01
—Morgan StanleyUnderweight——Reiterated2015-08-13
—OppenheimerOutperform——Reiterated2015-01-07
—Chardan CapitalBuy——Reiterated2014-11-07
—FBR CapitalUnderperform——Reiterated2014-08-14
—Chardan CapitalBuy——Reiterated2013-12-19
—Brean CapitalSell——Reiterated2013-12-17
—Craig-HallumBuy——Reiterated2013-09-13
—Stifel NicolausBuy——Reiterated2013-05-09
—Dawson JamesOutperform——Reiterated2012-11-27
—Stifel NicolausBuy——Reiterated2012-11-09
—Summer StreetBuy——Reiterated2012-04-11
—Stifel NicolausBuy——Reiterated2012-03-12

RMTI earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-260.40-0.10$18.6M$18.3M
2026-05-07-0.10-0.40$18.0M$17.3M
2026-08-13-0.23-0.34$17.8M$17.8M
2026-11-12-0.130.00$18.2M$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.